MHS, Johns Hopkins Bloomberg School of Public Health, 1998
FRACP, Royal Australasian College of Physicians, 1996
MD, University of Sydney, 1989
Dr Visvanathan is a physician-scientist. She is both a cancer epidemiologist and practicing medical oncologist. Dr. Visvanathan is Director of the Cancer Epidemiology Track, in the Department of Epidemiology at JHBSPH and Director of the Clinical Cancer Genetics and Prevention Service at the JH Sidney Kimmel Cancer Center. She is also a member of the Breast and Ovarian Cancer Program and Cancer Prevention and Control Program at the Cancer Center.
Dr. Visvanathan and her team conduct both epidemiological and clinical research focused on primary and secondary prevention of breast and ovarian cancer. Her research interests include: 1) improving risk stratification through the identification of breast cancer risk factors/biomarkers in blood, tissue and urine involved in inflammation, DNA repair, obesity, methylation, and vitamin D, 2) molecular characterization of breast and ovarian precursor tissue lesions as a target for prevention, 3) evaluating risk reduction strategies (i.e oophorectomy, hormonal prevention, sulforaphane, statins, aspirins and non-toxic preventive agents.
Dr. Visvanathan is an active member of multiple national working groups including the NCI Cohort Consortium, NCCN Breast Cancer Risk Reduction Guideline Committee, ECOG Breast Committee, and NRG co-operative trials Prev/Epi/Beh Committee. Dr. Visvanathan has previously co-chaired a national guideline on breast cancer chemoprevention and a working group on incorporating observational research into guidelines. She currently serves on the Maryland State Cancer Council and chairs the advisory board of the Maryland Cancer Registry.
Honors and Awards
1999 AACR-Glaxo Welcome Oncology Scholar Award for Clinical/Translational Research
2001 First Prize in Clinical section John’s Hopkins Fellow Research Day 2004 -2005
2005 ASCO Career Development Award 2005
2012, 2014 JHSPH Teaching Excellence Award
2017 Inducted into Delta Omega Honorary society for Public Health